Maladie à corps de LewyLa maladie à corps de Lewy (MCL), appelée aussi démence à corps de Lewy (DCL), est un type de démence partageant des caractéristiques avec la maladie d'Alzheimer et la maladie de Parkinson. Plus précisément, ce sont la maladie d'Alzheimer et la maladie de Parkinson qui partagent des caractéristiques avec la MCL, rendant difficile la distinction diagnostique entre ces deux dernières maladies. Un patient atteint de la maladie de Parkinson ou d'un syndrome parkinsonien peut aussi développer une MCL en parallèle (risque quatre fois plus important dans ce cas).
Sigma-2 receptorThe sigma-2 receptor (σ2R) is a sigma receptor subtype that has attracted attention due to its involvement in diseases such as cancer and neurological diseases. It is currently under investigation for its potential diagnostic and therapeutic uses. Although the sigma-2 receptor was identified as a separate pharmacological entity from the sigma-1 receptor in 1990, the gene that codes for the receptor was identified as TMEM97 only in 2017. TMEM97 was shown to regulate the cholesterol transporter NPC1 and to be involved in cholesterol homeostasis.
Dépression psychotiqueUne dépression psychotique désigne un état dépressif accompagné de symptômes psychotiques. Elle survient lors de contextes de trouble bipolaire ou de dépression. Il peut être difficile de différencier la schizophrénie dysthymique ; ce trouble requiert la présence de symptômes psychotiques pendant une période d'au moins deux semaines. Le Manuel diagnostique et statistique des troubles mentaux (DSM-IV) énonce un symptôme dépressif à caractère psychotique.
AsenapineAsenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder as well as the medium to long-term management of bipolar disorder. It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin. It was initially approved in the United States in 2009 and approved as a generic medication in 2020.
Intervalle QTvignette|Représentation d’un ECG normal L’intervalle QT désigne le laps de temps qui sépare les ondes Q et T sur le tracé d’un électrocardiogramme. Il quantifie le temps entre le début de dépolarisation des cellules myocardiques et leur repolarisation. Un effet secondaire classique de nombreuses classes de médicaments est l’allongement de cet intervalle QT. C'est le cas par exemple des neuroleptiques, des antipaludiques, des macrolides ou des fluoroquinolones.
Mixed affective stateA mixed affective state, formerly known as a mixed-manic or mixed episode, has been defined as a state wherein features unique to both depression and mania—such as episodes of despair, doubt, anguish, impulsive decision making or increased energy, suicidal ideation, decreased need for sleep, emotional liability, racing thoughts, irritability, pressure of activity, and heightened irritability—occur either simultaneously or in very short succession.
Tic disorderTic disorders are defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM) based on type (motor or phonic) and duration of tics (sudden, rapid, nonrhythmic movements). Tic disorders are defined similarly by the World Health Organization (ICD-10 codes). The fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published in May 2013, classifies Tourette syndrome and tic disorders as motor disorders listed in the neurodevelopmental disorder category.
DropéridolDroperidol /droʊˈpɛrIdɔːl/ (Inapsine, Droleptan, Dridol, Xomolix, Innovar [combination with fentanyl]) is an antidopaminergic drug used as an antiemetic (that is, to prevent or treat nausea) and as an antipsychotic. Droperidol is also often used as a rapid sedative in intensive-care treatment, and where "agitation aggression or violent behavior" are present. Discovered at Janssen Pharmaceutica in 1961, droperidol is a butyrophenone which acts as a potent D2 (dopamine receptor) antagonist with some histamine and serotonin antagonist activity.